Inflammatory bowel disease (ulcerative colitis). K51
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Age above 20 and less than 60 years Patients with mild to moderate ulcerative colitis Willingness to participate in the study
Exclusion criteria
Exclusion criteria: Changing the type of medicine used and its dosage during the last month Having other intestinal diseases (malignancies, infectious diseases) Suffering from other inflammatory diseases and kidney diseases and diabetes Pregnancy or breastfeeding Use of antibiotics, or use of pre- or probiotic products, or use of multivitamin and mineral supplements, or use of anti-inflammatory supplements such as w3 and curcumin during the intervention and in the one-month period before the intervention. Smoking and drug use History of hospitalization during the last three months
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Nutritional status. Timepoint: Before the intervention and 6 weeks later. Method of measurement: Anthropometric measurements including weight, height, and BMI calculation will be done and will be included in the questionnaire.;Inflammation. Timepoint: Before the intervention and 6 weeks later. Method of measurement: Eliza kit.;Quality of Life. Timepoint: Before the intervention and 6 weeks later. Method of measurement: Inflammatory bowel disease questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Complete blood cell count. Timepoint: Before the intervention and 6 weeks later. Method of measurement: Auto Analyzer device. | — |
Countries
Iran (Islamic Republic of)
Contacts
Tehran University of Medical Sciences